The Globe and Mail reports in its Thursday, Aug. 6, edition that investors are increasingly buying United States health care stocks, anticipating improved earnings, rising dealmaking and attractive valuations will sustain the sector's rebound. A Reuters dispatch to The Globe reports that this renewed interest mirrors a broader shift in investor positioning, with financials also gaining as Wall Street's rally expands beyond artificial intelligence linked technology companies. The S&P 500 Health Care Index has climbed 11.2 per cent in the past three months to hit a record high, outpacing the S&P 500's 6-per-cent rise. Around 50 U.S.-listed health care funds attracted $2.44-billion (U.S.) in July, extending June's nearly $1.5-billion (U.S.) inflow and reversing a three-month stretch of net withdrawals. "Health care offers a rare combination of durable growth, technology-like profitability, attractive valuation and diversification benefits at a time when many investors remain heavily concentrated in the AI theme," said JPMorgan analyst Dubravko Lakos-Bujas. A Bank of America survey showed global fund managers were net 32 per cent "overweight" on health care stocks in July, up sharply from 14 per cent in June.